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Summary The present study examined the association between abortion prior to a first livebirth and breast
cancer risk among a cohort of 3,315 women who had been delivered of liveborn children between 1946 and
1965 in a group of private gynaecology practices in Connecticut and followed through 1980 for the incidence
of cancer. Among women with one livebirth at the time of cohort identification, a spontaneous abortion
before this livebirth was associated with a 3.5-fold increase in the risk of breast cancer. The elevation in risk
was independent of some of the major risk factors of breast cancer and became more pronounced as the
number of years since the abortion increased.
Although abortion has generally not been
implicated as an important risk factor for breast
cancer, a recent case-control study found a
substantial increase in breast cancer risk among
women who experienced a first trimester abortion
prior to a first term pregnancy (Pike et al., 1981).
Of the two subsequent investigations examining this
issue, the first found no association (Vessey et al.,
1982) and the second, an increase in breast cancer
risk only among women who had two or more
short term pregnancies (less than 4 months
gestation) before their first livebirth (Brinton et al.,
1983). Given this uncertainty, the following report
will examine further the relationship between
abortion before a first livebirth and risk of breast
cancer.
Methods
The study uses data collected in the course of a
retrospective cohort study to examine the
association between exposure to exogenous
oestrogens during pregnancy, particularly DES
(CAS: 56-53-1; d, d'-diethyl-4, 4' - stilbendiol), and
subsequent risk of cancer (Hadjimichael et al.,
1984). The cohort consisted of 3,315 Connecticut
women who had been delivered of liveborn children
in 1946-65 in a group of 11 obstetric and
gynaecology practices located in Fairfield and New
Haven counties in the state of Connecticut. These
practices were selected on the basis of the
physician's willingness to participate in the study,
the number of records held since 1946 and the
completeness of record keeping.
Since this was a study of the health effects of
oestrogens, two groups of women qualified for the
Correspondence: O.C. Hadjimichael
Received 24 April 1985; and in revised form, 25
September 1985
study cohort. One group included women who were
prescribed oestrogens during a pregnancy that
resulted in a livebirth. Women with other
pregnancies, including abortions, in addition to the
index pregnancy, were all included in this group.
The other group included women whose medical
record contained no evidence that any oestrogenic
substance had been prescribed during any
pregnancy. Women with a history of abortions
were also included in this group as long as they had
not used oestrogrens.
Information on demographic characteristics and
reproductive and general medical history was
abstracted from the physicians' records by research
personnel trained in abstracting medical records.
Follow-up was accomplished through computerized
linkages of identifying information with the records
of the Motor Vehicle Department and Vital
Statistics of the State of Connecticut. Those not
identified as current drivers in the State, nor as
deceased, were traced to the end of 1980 through
city directories. The most frequent reason for
follow-up loss was migration from Connecticut.
Seventy percent of the cohort were followed
through 1980 or date of death. The remainder of
the cohort contributed person-years for the time
they were known to be alive in Connecticut. Breast
cancer cases were identified through computerized
linkages with the records of the Connecticut
Tumour Registry (CTR). All first primary breast
cancer cases found in CTR records for the cohort
occurred among women known from the described
follow-up sources to have been resident in
Connecticut at the time of diagnosis. The registry
attempts to ascertain all new cases of cancer
diagnosed among Connecticut residents, except
nonmelonoma skin cancer. Quality control
procedures indicate that -99% of reportable
cancers are recorded by the Connecticut Tumour
Registry (Devesa et al., 1984).
Incidence rates for breast cancer were based on
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person-years of follow-up. For women who
developed breast cancer, person years were
calculated up to the date of diagnosis. Cumulative
incidence rates were calculated using standard
survival analysis (Berkson, 1950). The effects of
possible confounding factors including age at
menarche, age at first livebirth, age at diagnosis,
parity, gravidity and exposure to exogenous
oestrogens during pregnancy, were evaluated
through the use of proportional hazards modelling
(Cox et al., 1972).
Information on induced abortions was not
available from medical records mainly because they
were illegal in the state of Connecticut during most
of the reproductive years of this cohort. Dates for
each additional pregnancy, other than the date of
the identifying livebirth which qualified a woman
for the study cohort, were not routinely recorded in
the medical records. Consequently, although we
knew which women had experienced spontaneous
abortions before the index livebirth, the only
women in this group whose abortions were known
to have preceded their first livebirth were those
whose index livebirth was their first. Thus, the risk
factor of interest, that is abortion prior to the first
livebirth, can only be examined among women with
one livebirth at the time of cohort selection. To
make this examination complete, the relationship
between ever having an abortion and breast cancer
risk among the remainder of the cohort will also be
presented.
Results
Table I presents the mean for selected variables
according to abortion status. Among women with
one livebirth at the time of study identification,
those with and without an abortion before this
pregnancy were similar with respect to their mean
years of follow-up and age at menarche. They
differed significantly in that women with an
abortion had an older mean age at entry into the
study as well as an older mean age at first livebirth
compared to those without an abortion.
Also presented in Table I are the mean years of
follow-up, age at entry, age at menarche, and age
at first livebirth for women with two or more
livebirths according to their abortion status. As
described above, we were not able to determine
when in the sequence of pregnancies the abortion
or abortions had occurred. In comparison of
women with and without an abortion across the
two parity groups, a similar relationship is found
for mean number of years of follow-up and age at
menarche. Among women with one livebirth, those
with an abortion prior to this livebirth had a later
age at first livebirth compared to those without an
abortion and the difference was statistically
significant. The difference in the mean age at first
livebirth by abortion status was found to be of
borderline significance for those with two or more
livebirths. The mean age at entry increased across
the four groups of women similarly to the increase
in their mean gravidity.
Table II shows the association between abortion
status and the risk of breast cancer. Among women
with one livebirth, an abortion prior to the livebirth
was associated with a 4.5-fold increase in breast
cancer risk. After adjusting for age at first livebirth
and age at menarche, which were found to be
significant effect modifiers, and exposure to
Table I Selected characteristics among parous women by number of livebirths in relation to the occurrence of an
abortion, Connecticut women, 1946-1982
Number oflivebirthsa
1 2+±
No abortion I+abortions P value No I+ P value
before before for abortions abortions for
(n=1226) (n=252) difference (n=1405) (n=417) difference
Mean years offollow-up 20.5 20.7 0.8 20.3 20.6 0.5
Mean age at menarche 12.6 12.5 0.4 12.7 12.8 0.3
Mean age at first livebirth 25.9 27.4 <0.01 24.4 24.9 0.05
Mean age at entry 26.0 27.8 <0.01 29.8 31.5 <0.01
Mean gravidity 1.0 2.3 <0.01 2.6 4.1 <0.01
Mean parity 1.0 1.0 2.6 2.6 0.3
Percentage exposed to
exogenous oestrogens 53.7 90.9 50.1 73.4
aThe number of livebirths at the time of study identification; bAs described above, we were not able to determine when
in the sequence ofpregnancies the abortion or abortions had occurred.ABORTION BEFORE FIRST LIVEBIRTH AND BREAST CANCER 283
Table II Breast cancer cases and person-years of follow-
up by parity status and abortion history, adjusted rate
ratios and 95% confidence intervals, Connecicut women,
1946-1982
Parity Abortion No. Person- Adjusted 95%
status status cases years RRb CI
Beforefirst
livebirth
I No 17 25,213 1.0a
Yes 16 5,222 3.5 1.7-7.4
Everc
2+ No 28 28,530 1.0a -
Yes 6 8,612 0.7 0.3-1.7
aReferent group; bAdjusted for age at first livebirth, age
at menarche and oestrogen use during pregnancy; CAs
described above, we were not able to determine when in
the sequence of pregnancies the abortion or abortions had
occurred.
exogenous oestrogens during pregnancy, the
magnitude of risk, although reduced to 3.5,
remained significantly elevated. In addition, when
risk factors were evaluated individually, this
elevation in breast cancer risk was evident
regardless of the number of abortions a woman had
before the first livebirth, whether or not she had
been exposed to exogenous oestrogens during
pregnancy, and irrespective of her age at the time
of menarche or at the time of her first livebirth.
The risk associated with ever having an abortion
for the remainder of the cohort, that is women with
two or more livebirths, is also presented in Table
II. Among this group an abortion did not increase
the risk of breast cancer.
Figure 1 presents the cumulative incidence of
breast cancer among women with one livebirth by
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Figure 1 Life table estimate of cumulative incidence
of breast cancer among women with one livebirth
according to history of abortion. (0) Women with
history of abortion prior to livebirth; (A) women with
no history of abortion.
whether or not they had an abortion before the
livebirth. During the first 20 years of follow-up,
there is only a slight elevation in the risk of breast
cancer associated with abortion before a first
livebirth. After 20 years the risk of breast cancer
increases much more sharply among women with
an abortion before a first livebirth compared to
those without.
Because this cohort experienced breast cancer at
a much later age than the women studied in the
initial investigation suggesting the abortion
association (Pike et al., 1981), it was of interest to
determine if the risk of breast cancer associated
with spontaneous abortions varied with age at
diagnosis. Although there were too few breast
cancer cases diagnosed before the age of 40 (only 2)
to allow for a stable estimate of risk, some
difference was seen in the magnitude of risk among
women diagnosed before age 50 (Rate ratio,
RR=4.1; 95% Confidence interval, CI=1.5-11.3)
and after age 50 (RR=2.8; 95% CI=0.9-8.5).
Discussion
From a cohort of women assembled to examine the
effect of oestrogen therapy given during pregnancy
on cancer risk, it was found that among women
with one livebirth, a spontaneous abortion before
this birth was associated with an adjusted 3.5-fold
increase in the risk of breast cancer relative to
women with no history of abortion. It was not
possible to adjust for some of the known effect
modifiers such as family history of breast cancer,
benign breast disease, menopausal status and age at
menopause. However, the elevation in risk was
independent of some of the major risk factors of
breast cancer, did not increase with the number of
abortions occurring before the first livebirth and
became more pronounced as the number of years
since the abortion increased.
The present analysis was focused on women with
one livebirth at the time of cohort identification.
Among the remainder of the cohort, which included
women with two or more livebirths, although the
number of abortions was known, the dates of these
events in relation to the livebirths was not. Among
these women, an abortion was not associated with
an increased risk of breast cancer. Since some of
these abortions undoubtedly were the flrst
pregnancy, if the observed association between
abortion and breast cancer is real, the risk among
women with two or more livebirths at the time of
cohort identification should also be elevated,
although less so than among the group with only
one livebirth. One possible explanation for the
absence of such a finding is suggested by the
observation of Pike et al. (1981) that the breast284 C. HADJIMICHAEL et al.
cancer risk associated with abortion before the first
livebirth was reduced among women who
subsequently carried a pregnancy to term. Thus, in
the present study, the risk among women with two
or more livebirths may have been reduced because
of these subsequent pregnancies. There may also be
other factors associated with number of liveborn
children that affect the possible links between
abortion and breast cancer.
Experimental work with rats (Russo et al., 1980)
suggests that pregnancy and lactation reduce the
susceptibility of these animals to benign lesions and
carcinomas by means of induction of full
differentiation of the mammary gland. Russo et al.
(1980) found that pregnancy interruption prevents
sufficient differentiation in the gland to be
protective. They reported that 77% of their
experimental animals developed carcinomas and all
of them developed benign lesions. The authors see
a parallelism between the animal model and the
human experience since in women during gestation
there is increased secretion of oestrogen, pro-
gesterone and prolactin which together promote
breast growth and differentiation. Abortion
interrupts this process and leads to incomplete
development of the mammary gland which may
render it susceptible to carcinogenesis.
It is possible that the risk observed in this study
reflects a bias introduced either in the seclection of
the cohort or in its follow-up. Given that there was
a similar percent of women with partial follow-up
among those with a first pregnancy terminating in
an abortion and those with no history of such an
abortion, differential follow-up does not seem to be
a likely alternative explanation. With regard to a
bias introduced in the selection of the cohort, there
is excellent agreement between the magnitude of
breast cancer risk observed with the present cohort
for oestrogen use during pregnancy compared to
that found in another larger cohort (Greenberg et
al., 1984). The possibility of chance findings due to
the small number of breast cancer cases cannot be
ruled out.
In summary, these data indicate that an abortion
prior to the first livebirth may increase a woman's
risk of breast cancer. Whether this is the result of
incomplete development of the mammary gland due
to the interrupted pregnancy or of a hormonal
imbalance that may result in both the spontaneous
abortion and the cancer of the breast, or of some
unsuspected factor, it is clear that further
exploration of this issue is warranted.
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